PlainRecalls
FDA Drug Low Class III Terminated

Cardizem CD (diltiazem HCl) capsules, 240 mg, packaged in a) 30-count bottles (NDC 0187-0797-30); and b) 90-count bottles (NDC 0187-0797-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

Reported: February 20, 2019 Initiated: January 30, 2019 #D-0489-2019

Product Description

Cardizem CD (diltiazem HCl) capsules, 240 mg, packaged in a) 30-count bottles (NDC 0187-0797-30); and b) 90-count bottles (NDC 0187-0797-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

Reason for Recall

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Details

Units Affected
390 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Cardizem CD (diltiazem HCl) capsules, 240 mg, packaged in a) 30-count bottles (NDC 0187-0797-30); and b) 90-count bottles (NDC 0187-0797-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.. Recalled by Valeant Pharmaceuticals North America LLC. Units affected: 390 bottles.
Why was this product recalled?
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 20, 2019. Severity: Low. Recall number: D-0489-2019.